- Home
- VEEA vs ZBIO Comparison
VEEA vs ZBIO Comparison
Compare VEEA & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEA
- ZBIO
- Stock Information
- Founded
- VEEA 2014
- ZBIO 2019
- Country
- VEEA United States
- ZBIO United States
- Employees
- VEEA N/A
- ZBIO N/A
- Industry
- VEEA
- ZBIO
- Sector
- VEEA
- ZBIO
- Exchange
- VEEA NYSE
- ZBIO NYSE
- Market Cap
- VEEA 83.9M
- ZBIO 389.2M
- IPO Year
- VEEA N/A
- ZBIO 2024
- Fundamental
- Price
- VEEA $1.68
- ZBIO $11.18
- Analyst Decision
- VEEA
- ZBIO Strong Buy
- Analyst Count
- VEEA 0
- ZBIO 7
- Target Price
- VEEA N/A
- ZBIO $32.29
- AVG Volume (30 Days)
- VEEA 29.4K
- ZBIO 180.5K
- Earning Date
- VEEA 08-23-2025
- ZBIO 08-16-2025
- Dividend Yield
- VEEA N/A
- ZBIO N/A
- EPS Growth
- VEEA N/A
- ZBIO N/A
- EPS
- VEEA N/A
- ZBIO N/A
- Revenue
- VEEA $139,252.00
- ZBIO $15,000,000.00
- Revenue This Year
- VEEA N/A
- ZBIO $165.20
- Revenue Next Year
- VEEA N/A
- ZBIO $63.75
- P/E Ratio
- VEEA N/A
- ZBIO N/A
- Revenue Growth
- VEEA N/A
- ZBIO N/A
- 52 Week Low
- VEEA $1.33
- ZBIO $5.83
- 52 Week High
- VEEA $18.56
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- VEEA N/A
- ZBIO N/A
- Support Level
- VEEA N/A
- ZBIO N/A
- Resistance Level
- VEEA N/A
- ZBIO N/A
- Average True Range (ATR)
- VEEA 0.00
- ZBIO 0.00
- MACD
- VEEA 0.00
- ZBIO 0.00
- Stochastic Oscillator
- VEEA 0.00
- ZBIO 0.00
About VEEA VEEA INC
Veea Inc is a company providing an edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. The company has first-in-class VeeaHub smart connectivity and computing hubs that integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.